Search Results - robert+schiestl

2 Results

Sort By:

Method for Combined Conditioning and Chemoselection in a Single Cycle (UCLA Case No. 2011-478)

SUMMARY: Researchers at UCLA have developed a highly-efficient technique to engraft and select hematopoietic stem cells directly inside a patient. The invention will improve the fidelity of stem cell transplantations and reduce toxic side effects on patients. BACKGROUND: Hematopoietic stem cell transplantation (HSCT) is a mainstay of treatment for...

Published: 2/16/2024 | Inventor(s): Gay Crooks, Robert Schiestl, Katrin Hacke, Akos Szakmary

Keywords(s): blood cancers, Cancer stem cells, Hematopoietic stem cell transplantation, hematopoietic stem cells, lymphatic cancer, stem cell transplantations, Transplant

Category(s): Therapeutics > Stem Cells And Regenerative Medicine, Therapeutics > Transplant

2009-341 GENOTOXICITY AS A BIOMARKER FOR INFLAMMATION

Genotoxicity As A Biomarker For InflammationSUMMARYResearchers at the UCLA Departments of Pathology and Laboratory Medicine have identified a means to use systemic genotoxicity as a sensitive biomarker for mucosal inflammation, pulmonary inflammation, and their progression to inflammatory bowel disease-associated dysplasia and asthma.BACKGROUNDChronic...

Published: 7/19/2023 | Inventor(s): Robert Schiestl, Jonathan Braun, Bo Wei, Aya Westbrook

Keywords(s): Diagnostic Markers & Platforms, Inflammatory Diseases

Category(s): Diagnostic Markers, Therapeutics > Inflammation And Inflammatory Diseases